Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Crocs Sees Double-Digit Growth Acceleration Overseas: https://www.marketbeat.com/logos/articles/med_20230409120400_chart-crox.jpg
Crocs Sees Double-Digit Growth Acceleration Overseas

Crocs, Inc. (NASDAQ: CROX) has evolved from a clogs maker to a global lifestyle brand that produces various types of shoes, accessories, and apparel. Its clogs are diversified and evolved into

NIO Could Bring A Pleasant Beat This Coming Quarter: https://www.marketbeat.com/logos/articles/med_20230409184500_nio-could-bring-a-pleasant-beat-this-coming-quarte.jpg
NIO Could Bring A Pleasant Beat This Coming Quarter

The electric vehicle market has become a battlefield lately, with companies coming in and out of favor almost overnight in the space. The success of the industry's value proposition was given a

Alibaba's Turn At Bat For ChatGPT Competition, How to Manage Risk: https://www.marketbeat.com/logos/articles/20230407142221_baba20d.jpg
Alibaba's Turn At Bat For ChatGPT Competition, How to Manage Risk

When the Soviet Union and the United States began the fierce race to space that gave birth to the ultimate tension termed the "cold war," the U.S. Pentagon, alongside NASA, picked up the phone and

2 Under-The-Radar Small Chip Stocks Poised For Big Growth: https://www.marketbeat.com/logos/articles/med_20230409184914_2-under-the-radar-small-chip-stocks-poised-for-big.jpg
2 Under-The-Radar Small Chip Stocks Poised For Big Growth

Chip stocks are certainly having a moment, with the sub-industry consisting of fabless semiconductor makers being a top market leader. Nvidia Corp. (NASDAQ: NVDA) is among the S&P 500’s biggest

Novartis Shares Leap On Positive Clinical Trial Data: https://www.marketbeat.com/logos/articles/med_20230409190052_novartis-shares-leap-on-positive-clinical-trial-da.jpg
Novartis Shares Leap On Positive Clinical Trial Data

If you’re looking to jump onboard a rocket, forget Jeff Bezos and Richard Branson. Shares of Swiss pharmaceutical giant Novartis AG (NYSE: NVS) catapulted 5.11% in the past week and 17.47% in the

ACCESSWIRE - HotelRunner Introduces 'Elite': An Exclusive Path to Efficiency and Profitability: https://www.irw-press.at/prcom/images/messages/2023/70012/HotelRunnerIntroduces_04-10-23.001.jpeg
ACCESSWIRE - HotelRunner Introduces 'Elite': An Exclusive Path to Efficiency and Profitability

HotelRunner, the leading hospitality and travel technologies platform, has launched HotelRunner Elite, an exclusive service designed to add exponential value to independent and chain hotels,

Costco Sales Disappoint, Markets Are Missing This Upside Driver: https://www.marketbeat.com/logos/articles/med_20230407105751_costco-sales-disappoint-markets-are-missing-this-u.png
Costco Sales Disappoint, Markets Are Missing This Upside Driver

The United States added 236,000 jobs in March, signaling increased economic activity for specific sectors of the economy despite FED efforts to slow down the economy and cool the labor market

First Republic Bank Is A Speculative Play; Here’s Why: https://www.marketbeat.com/logos/articles/med_20230407095105_first-republic-bank-is-a-speculative-play-heres-wh.jpg
First Republic Bank Is A Speculative Play; Here’s Why

While First Republic Bank NYSE: FRC) remains too risky for average investors, it is an interesting speculative play. Given the suitable catalysts, the company has value despite its risk and could

The WD-40 Company Bottoms With Reversal In Sight: https://www.marketbeat.com/logos/articles/med_20230407081944_the-wd-40-company-bottoms-with-reversal-in-sight.jpg
The WD-40 Company Bottoms With Reversal In Sight

The WD-40 Company (NYSE: WDFC) is facing headwinds like the rest of the market, but it is in a position to unstick the cogs of profitability and send its stock into a reversal. The company has

3 Low-Cost Stock ETFs That Are Crushing It This Year: https://www.marketbeat.com/logos/articles/med_20230407074940_3-low-cost-stock-etfs-that-are-crushing-it-this-ye.jpg
3 Low-Cost Stock ETFs That Are Crushing It This Year

In a recovery year for global equities, investment returns are all over the ‘map.’

Major U.S. indices are up but lagging developed international peers. The growth investment style is

FedEx Takes Flight; Analysts See More Gains Ahead: https://www.marketbeat.com/logos/articles/med_20230406144447_fdx.jpg
FedEx Takes Flight; Analysts See More Gains Ahead

FedEx Corp. (NYSE: FDX) delivered for investors on April 6, with shares flying 1% higher, driven by heavier-than-normal trading volume. 

The price move followed the company’s announcement at an

Walmart Makes Moves for Efficiency with Robots to Spur Sales: https://www.marketbeat.com/logos/articles/med_20230407074048_walmart-makes-moves-for-efficiency-with-robots-to.jpg
Walmart Makes Moves for Efficiency with Robots to Spur Sales

Walmart Inc. (NYSE: WMT) may not be the first thing that pops into your mind when you think of AI, robotics, and machine learning, but it’s all coming to a Wally World near you. 

Efficiency has

Moderna: MRNA-4157/V940, an Investigational Personalized MRNA Cancer Vaccine, in Combination With Keytruda(R) (Pembrolizumab), Receives Prime Scheme Designation From the European Medicines Agency for Adjuvant Treatment of Patients With High-Risk Stag: https://mms.businesswire.com/media/20210106005629/en/850492/5/KO_LOGO_%28002%29.jpg
Moderna: MRNA-4157/V940, an Investigational Personalized MRNA Cancer Vaccine, in Combination With Keytruda(R) (Pembrolizumab), Receives Prime Scheme Designation From the European Medicines Agency for Adjuvant Treatment of Patients With High-Risk Stag

MRNA-4157/V940, an Investigational Personalized MRNA Cancer Vaccine, in Combination With Keytruda(R) (Pembrolizumab), Receives Prime Scheme Designation From the European Medicines Agency for

What Factors Will Drive S&P 500 Performance This Year?: https://www.marketbeat.com/logos/articles/med_20230406144923_what-factors-will-drive-sp-500-performance-this-ye.jpg
What Factors Will Drive S&P 500 Performance This Year?

If there’s one question investors are always pondering, it’s this: Where is the market headed? 

Many investors feel a sense of relief after the broad markets rebounded in the first quarter. Some

2 Beautiful Investments In A Growing Industry: https://www.marketbeat.com/logos/articles/med_20230406110626_chart-ulta-462023.png
2 Beautiful Investments In A Growing Industry

Beauty stocks are outperforming their expectations and trending higher. The trend is supported by the analysts raising their ratings and price targets because of the robust outlook. The guidance

Hypercharge Networks: Up Triple Digits, But What’s The Big Deal?: https://www.marketbeat.com/logos/articles/med_20230406123514_hypercharge-networks-up-triple-digits-but-whats-th.jpg
Hypercharge Networks: Up Triple Digits, But What’s The Big Deal?

You are not alone in wondering what Hypercharge Networks (OTCMKTS: HCNWF) is. This under-the-radar Canadian-based and focused EV start-up has come out of nowhere to electrify its market. The stock

3 Reasons Why Apple’s 30% Rally Has Legs: https://www.marketbeat.com/logos/articles/med_20230406115230_3-reasons-why-apples-30-rally-has-legs.png
3 Reasons Why Apple’s 30% Rally Has Legs

Despite equities having cooled somewhat this week following a strong end to Q1, Apple Inc’s (NASDAQ: AAPL) 30% rally looks as strong as ever. Since tagging that multi-year low at the start of the

3 Reasons to Pick First Citizens Instead of First Republic: https://www.marketbeat.com/logos/articles/med_20230406114257_3-reasons-to-pick-first-citizens-instead-of-first.jpg
3 Reasons to Pick First Citizens Instead of First Republic

One man’s loss is another man’s gain, or so the saying goes. As the fallout from last month’s collapse of SVB continues to ripple through the marketplace, perhaps the saying has never been truer

3 April Earnings Plays for Bullish Swing Traders: https://www.marketbeat.com/logos/articles/med_20230406101135_3-april-earnings-plays-for-bullish-swing-traders.png
3 April Earnings Plays for Bullish Swing Traders

The spring season is finally upon us! Time to pull out the raincoat, plant some seeds and put that green thumb to use.

If you’re a stock trader, it’s also a time to put on the thinking cap. First

Is Constellation Brands Star About To Rise?: https://www.marketbeat.com/logos/articles/med_20230406093943_is-constellation-brands-star-about-to-rise.jpg
Is Constellation Brands Star About To Rise?

Constellation Brands (NYSE: STZ) shares have been under pressure all year, but that may be changing. The Q4 results were better than expected and point to continued consolidation of the company’s

Lamb Weston Serves Sizzling Report; Rally Sets New High: https://www.marketbeat.com/logos/articles/med_20230406081627_copy-1-of-chart-lw-462023.png
Lamb Weston Serves Sizzling Report; Rally Sets New High

Lamb Weston (NYSE: LW) is not an exciting stock, and that is saying something for the Consumer Staples sector. This company makes potato products, and that’s it, but it is delivering value to

Valero Has The Value Proposition Energy Investors Need: https://www.marketbeat.com/logos/articles/med_20230405212854_vlocomps.jpg
Valero Has The Value Proposition Energy Investors Need

Electric cars have been the hot issue of the past five years as companies like Tesla (NASDAQ: TSLA) take over the podium to deliver all the benefits of switching from fossil fuel dependency to the

RPM International Pulls Back Critical Levels; Is It Time To Buy?: https://www.marketbeat.com/logos/articles/med_20230406072934_chart-rpm-ppg-462023.png
RPM International Pulls Back Critical Levels; Is It Time To Buy?

Shares of RPM International (NYSE: RPM) are pulling back to critical levels following the Q3 report and guidance, but it might be the time to buy. The report was strong and guidance positive if

Is the Dutch Bros.’ Outperform Upgrade Just the Beginning?: https://www.marketbeat.com/logos/articles/med_20230406074357_is-the-dutch-bros.png
Is the Dutch Bros.’ Outperform Upgrade Just the Beginning?

Dutch Bros Coffee (NYSE: BROS) share value suddenly jumped nearly 4% on April 5 as Wedbush analysts upgraded the stock from Neutral to Overweight (also known as Outperform or Moderate Buy).  It

UiPath is a Cheaper and More Profitable AI Stock: https://www.marketbeat.com/logos/articles/med_20230402100126_chartyt-path.jpg
UiPath is a Cheaper and More Profitable AI Stock

 

With the mainstream popularity of ChatGPT, artificial intelligence (AI) has been all the rage in 2023. The AI wars between Microsoft Co. (NASDAQ: MSFT) investment in ChatGPT parent OpenAI